Section Arrow
ABVC.NASDAQ
- ABVC BioPharma
Quotes are at least 15-min delayed:2026/03/20 11:38 EDT
Regular Hours
Last
 1.22
-0.07 (-5.43%)
Day High 
1.37 
Prev. Close
1.29 
1-M High
1.6744 
Volume 
22.91K 
Bid
1.22
Ask
1.23
Day Low
1.22 
Open
1.32 
1-M Low
1.18 
Market Cap 
31.35M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.35 
20-SMA 1.38 
50-SMA 1.71 
52-W High 5.48 
52-W Low 0.6871 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.39/-0.46
Enterprise Value
32.95M
Balance Sheet
Book Value Per Share
0.44
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.03
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AZTRAzitra0.2768+0.1007+57.18%-- 
LNAILunai Bioworks Inc.0.4754+0.0904+23.48%-- 
HUMAHumacyte0.7961-0.058-6.79%-- 
IBRXImmunityBio9.125+0.305+3.46%-- 
ARTLArtelo Biosciences Inc8.66+1.5+20.95%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.